American Academy of Neurology Annual Meeting

Longer-term treatment with ofatumumab led to lessening of disability progression and slowing of brain volume loss, according to Jeffrey A. Cohen, MD, in this Healio video.

Treatment with inebilizumab was effective in reducing two telltale signs of an attack of neuromyelitis optica spectrum disorder, Bruce A. Cree, MD, PhD, MAS, said in this Healio video.

BOSTON — Initiating treatment with a high-efficacy therapeutic such as ocrelizumab as early as possible is effective for those with multiple sclerosis, according to a presenter at the American Academy of Neurology annual meeting.

BOSTON — With a multitude of products spanning neuroscience and psychiatry, executives at AbbVie say they are committed to learning the full clinical value of all of the company’s products for the benefit of patients.

BOSTON – Diversity in the medical profession is crucial, and tapping into underrepresented populations to achieve that goal with a solid foundation of mentorship is key, according to Alyx B. Porter, MD, in this Healio video.

Reata Pharmaceuticals announced that Skyclarys is now commercially available for patients older than 16 years who have Friedreich’s ataxia, a rare degenerative neuromuscular disorder that manifests at a young age.

BOSTON — More than half of patients with early MS had no disease progression over 9 years when taking Ocrevus, according to Ashish Pradhan, MD, in this Healio video.

BOSTON — The BrainPath device successfully surgically evacuated intracerebral hemorrhages in most patients enrolled in the ENRICH trial, Andrew Russman, DO, said in a Healio video during the American Academy of Neurology Annual Meeting.

BOSTON — Relapse rates for patients with MS who took dimethyl fumarate were consistently low over the course of 5 years, Krupa Shah Pandey, MD, said in this Healio video.

BOSTON — In honor of Stroke Awareness Month, two vascular neurologists from the University of Virginia spoke with Healio at the American Academy of Neurology annual meeting about the importance of recognizing risk factors in all patients.